Previous 10 | Next 10 |
An affiliate of private equity shop Permira Funds has agreed to acquire contract manufacturer Cambrex (NYSE: CBM ) for $60 per share in cash representing a transaction value of ~$2.4B. More news on: Cambrex Corporation, Healthcare stocks news, Merger & acquisition news, Read more...
EAST RUTHERFORD, N.J., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, announced today that it has signed a definitive agreement to be acqui...
EAST RUTHERFORD, N.J., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, today announced that second quarter 2019 financial results will be re...
EAST RUTHERFORD, N.J., July 30, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, today announced that it is expanding its solid form screening and cry...
EAST RUTHERFORD, N.J., June 26, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, today announced three senior appointments to further support the comp...
EAST RUTHERFORD, N.J., June 25, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, today announced that Dottie Donnelly-Brienza has been appointed Senio...
The following slide deck was published by Cambrex Corporation in conjunction with this Read more ...
EAST RUTHERFORD, N.J., June 04, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, today announced that it has completed a new 600 m 2 facility at its ...
EAST RUTHERFORD, N.J., May 29, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, today announced that company management will present at the following ...
Cambrex Corporation (CBM) Q1 2019 Earnings Conference Call May 2, 2019 8:30 AM ET Company Participants Gregory Sargen - Chief Financial Officer and Executive Vice President, Corporate Development and Strategy Steven Klosk - President and Chief Executive Officer Conference Call P...
News, Short Squeeze, Breakout and More Instantly...
Cambrex Corporation Company Name:
CBM Stock Symbol:
NYSE Market:
ENGLEWOOD CLIFFS, N.J., June 11, 2024 (GLOBE NEWSWIRE) -- ConnectOne Bank (“ConnectOne”), the wholly-owned depository subsidiary of ConnectOne Bancorp, Inc. (NASDAQ: CNOB), today announces the addition of seasoned financial services consultant Susan O’Donnell to its Board of ...
ENGLEWOOD CLIFFS. N.J., April 25, 2024 (GLOBE NEWSWIRE) -- ConnectOne Bancorp, Inc. (Nasdaq: CNOB) (the “Company” or “ConnectOne”), parent company of ConnectOne Bank (the “Bank”), today reported net income available to common stockholders of $15.7 million...
ENGLEWOOD CLIFFS, N.J., April 11, 2024 (GLOBE NEWSWIRE) -- ConnectOne Bancorp, Inc. (Nasdaq: CNOB) (the “Company” or “ConnectOne”), parent company of ConnectOne Bank (the “Bank”), today announced that it plans to release results for the first quarter ende...